These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7554175)

  • 1. New standard for success of thrombolytic therapy. An earnest proposal.
    Forrester JS
    Circulation; 1995 Oct; 92(8):2026-8. PubMed ID: 7554175
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrolase, an active thrombolytic enzyme in arterial and venous thrombosis model systems.
    Markland FS
    Adv Exp Med Biol; 1996; 391():427-38. PubMed ID: 8726081
    [No Abstract]   [Full Text] [Related]  

  • 3. Applications of thrombolytic therapy.
    Curzen N; Haque R; Timmis A
    Intensive Care Med; 1998 Aug; 24(8):756-68. PubMed ID: 9757918
    [No Abstract]   [Full Text] [Related]  

  • 4. Thrombolytic therapy of peripheral arterial occlusion with recombinant staphylokinase.
    Vanderschueren S; Stockx L; Wilms G; Lacroix H; Verhaeghe R; Vermylen J; Collen D
    Circulation; 1995 Oct; 92(8):2050-7. PubMed ID: 7554181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolytic solutions for vascular thrombotic events: summary and conclusions.
    Ouriel K
    Rev Cardiovasc Med; 2002; 3 Suppl 2():S100-3. PubMed ID: 12556749
    [No Abstract]   [Full Text] [Related]  

  • 6. Reteplase: nursing implications for catheter-directed thrombolytic therapy for peripheral vascular occlusions.
    Bussard ME
    Crit Care Nurse; 2002 Jun; 22(3):57-63. PubMed ID: 12092294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splenic rupture: an additional complication of thrombolytic therapy.
    Summers JB
    Crit Care Nurse; 2002 Oct; 22(5):18-9; author reply 19-20. PubMed ID: 12382613
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug evaluation: alfimeprase, a plasminogen-independent thrombolytic.
    Shah AR; Scher L
    IDrugs; 2007 May; 10(5):329-35. PubMed ID: 17487785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin-selective thrombolytic therapy with recombinant staphylokinase.
    Collen D; Vanderschueren S; Van de Werf F
    Haemostasis; 1996 Oct; 26 Suppl 4():294-300. PubMed ID: 8979135
    [No Abstract]   [Full Text] [Related]  

  • 10. The ideal fibrinolytic: can drug design improve clinical results?
    Van de Werf FJ
    Eur Heart J; 1999 Oct; 20(20):1452-8. PubMed ID: 10493843
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombolytic efficacy of native recombinant staphylokinase on femoral artery thrombus of rabbits.
    Li CJ; Huang J; Yang ZJ; Cao KJ
    Acta Pharmacol Sin; 2007 Jan; 28(1):58-65. PubMed ID: 17184583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'STAR' war against coronary thrombosis.
    Gambhir DS; Gambhir J
    Indian Heart J; 1995; 47(5):459-60. PubMed ID: 8714497
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombolytic therapy.
    Lawrence PF; Goodman GR
    Surg Clin North Am; 1992 Aug; 72(4):899-918. PubMed ID: 1496443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombolytic therapy: new dimensions 2009.
    Guha S; Mukherjee S; Hema MB
    Indian Heart J; 2009; 61(5):415-21. PubMed ID: 20635755
    [No Abstract]   [Full Text] [Related]  

  • 15. [Staphylokinase for a better thrombolytic treatment of heart and platelet diseases].
    Vanderschueren S
    Verh K Acad Geneeskd Belg; 2000; 62(1):69-75. PubMed ID: 10769618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic therapies in the treatment of peripheral vascular disease: clinical experience with reteplase, a third-generation thrombolytic.
    Laird JR
    J Invasive Cardiol; 2000 Mar; 12 Suppl B():27B-32B. PubMed ID: 10731297
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of tenecteplase in peripheral embolic disease.
    Bannerjee AK; Dastidar DG
    Indian Heart J; 2010; 62(4):313-5. PubMed ID: 21280470
    [No Abstract]   [Full Text] [Related]  

  • 18. Antithrombotic therapy in peripheral arterial occlusive disease.
    Clagett GP; Graor RA; Salzman EW
    Chest; 1992 Oct; 102(4 Suppl):516S-528S. PubMed ID: 1395832
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of thrombolytic agents.
    Whelan MF; O'Toole TE
    Compend Contin Educ Vet; 2007 Aug; 29(8):476-82; quiz 482, 486. PubMed ID: 17849701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral vascular disease, Part 2.
    Bajwa TK; Shalev YA; Gupta A; Khalid MA
    Curr Probl Cardiol; 1998 Jun; 23(6):305-48. PubMed ID: 9640544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.